Final answer:
The statement which related to Multiple Myeloma are ``*AKA plasma cell sarcoma, Typical patient is *over 50*,complaining of *cachexia, weight loss, anemia* and Malignant proliferation of plasma cells infiltrating bone marrow.``
The answer is option ⇒1,2,3 and 4
Step-by-step explanation:
Multiple Myeloma, also known as plasma cell sarcoma, is a type of cancer characterized by the malignant proliferation of plasma cells that infiltrate the bone marrow.
Here's a breakdown of the key points:
- 1. AKA plasma cell sarcoma: Multiple Myeloma is another name for plasma cell sarcoma. This cancer originates from abnormal plasma cells, which are a type of white blood cell involved in immune responses.
- 2. Typical patient is over 50: Multiple Myeloma is commonly diagnosed in individuals who are over the age of 50. However, it can occur in people of any age.
- 3. Common symptoms: Patients with Multiple Myeloma often experience cachexia, which is severe weight loss and muscle wasting. They may also complain of anemia, which is a low red blood cell count. These symptoms can be indicators of the disease.
- 4. Malignant proliferation of plasma cells infiltrating bone marrow: Multiple Myeloma is characterized by the uncontrolled growth of abnormal plasma cells that invade and replace the normal cells in the bone marrow. This can disrupt the production of healthy blood cells and lead to the symptoms mentioned earlier.
It's important to consult a healthcare professional for a proper evaluation and diagnosis if you or someone you know is experiencing these symptoms or suspects they may have Multiple Myeloma. Medical professionals can provide accurate information and guide you through appropriate treatment options.
The answer is option ⇒1,2,3 and 4
Your question is incomplete, but most probably the full question was:
Which of the following that related to *Multiple Myeloma*?
- *1* AKA plasma cell sarcoma.
- *2* Typical patient is *over 50*
- *3* complaining of *cachexia, weight loss, anemia*
- *4* Malignant proliferation of plasma cells infiltrating bone marrow.